Sleep Aids (Pharmacies) - CIS

  • CIS
  • Revenue in the Sleep Aids market is projected to reach US$87.89m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -1.06%, resulting in a market volume of US$83.31m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.36 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in CIS is witnessing significant growth due to changing customer preferences and increasing demand for sleep aids.

Customer preferences:
Customers in CIS are becoming more aware of the importance of sleep and the impact it has on their overall health and well-being. As a result, there is a growing demand for sleep aids in the region. Customers are actively seeking out products that can help them improve the quality of their sleep and address common sleep disorders such as insomnia.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in CIS is the increasing popularity of natural and herbal sleep aids. Customers are increasingly looking for products that are derived from natural ingredients and have minimal side effects. This trend is driven by the growing preference for organic and natural products across various consumer segments. Another trend in the market is the rising demand for over-the-counter sleep aids. Customers are seeking convenience and accessibility when it comes to purchasing sleep aids, and over-the-counter options provide them with the flexibility to buy these products without a prescription. This trend is also supported by the increasing number of pharmacies and retail outlets in CIS, making sleep aids more easily available to customers.

Local special circumstances:
CIS is a diverse region with different countries having their own unique cultural and economic factors that influence the Sleep Aids (Pharmacies) market. For example, countries like Russia and Kazakhstan have a large population and a growing middle class, which drives the demand for sleep aids. On the other hand, countries like Armenia and Kyrgyzstan have a smaller population and a less developed healthcare infrastructure, which can limit the availability and accessibility of sleep aids.

Underlying macroeconomic factors:
The Sleep Aids (Pharmacies) market in CIS is also influenced by macroeconomic factors such as the overall economic growth of the region, disposable income levels, and healthcare expenditure. As the economies of CIS countries continue to grow, disposable income levels are increasing, allowing customers to spend more on healthcare products, including sleep aids. Additionally, the increasing healthcare expenditure in the region is driving the development of the healthcare infrastructure and the availability of sleep aids in pharmacies. In conclusion, the Sleep Aids (Pharmacies) market in CIS is experiencing growth due to changing customer preferences, increasing demand for sleep aids, and the availability of over-the-counter options. The trend towards natural and herbal sleep aids is also shaping the market, driven by the preference for organic and natural products. However, the market is influenced by local special circumstances, such as the varying healthcare infrastructure and economic conditions in different countries within CIS. Overall, the market is expected to continue growing as customers prioritize their sleep health and seek out products that can help them improve their sleep quality.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)